Hipertiroidismo primario con nefrolitiasis en mujer menopaúsica a propósito de un caso
| dc.contributor.author | Arias Loyola, María Luisa | |
| dc.contributor.author | Rojas, Joselyn | |
| dc.contributor.author | Bermúdez, Valmore | |
| dc.date.accessioned | 2020-01-29T22:07:31Z | |
| dc.date.available | 2020-01-29T22:07:31Z | |
| dc.date.issued | 2019 | |
| dc.description.abstract | Introducción: El hiperparatiroidismo primario es el aumento en los niveles de paratohormona (PTH), su cuadro clínico se caracteriza por síntomas de hipercalcemia, nefrolitiasis, enfermedad mineral ósea, síntomas neuromusculares, también existen cuadros asintomáticos; la nefrolitiasis ocurre en un 4 a 15% de los pacientes, y esta enfermedad suele aparecer en mujeres en la menopausia. Caso Clínico: Paciente femenina de 65 años de edad, que presenta cuadro clínico caracterizado por dolor en hipogastrio de leve intensidad que se irradia a región lumbar se acompaña de disuria, poliuria, coluria, tenesmo vesical y cefalea de moderada intensidad, la paciente refiere recurrencias de este cuadro clínico. Sus exámenes de laboratorio revelan estos datos calcemia de 12 mg/dl, calciuria 310 mg/24 horas, fosfatemia 2.1 mg/dl, fosforo en orina 150 mg/24 horas, magnesio 2.2 mg/dl, PTH 120 pg/ml con lo que se realiza el diagnostico de hiperparatiroidismo primario. Su ecografía renal muestra cálculos renales bilaterales y su densitometria ósea demuestra osteopenia en columna lumbar y osteoporosis en cabeza del femur con T score -1 y -2 respectivamente. Se piden otros exámenes complementarios y se recomienda alendronato y cirugía de paratiroides. Conclusiones: El mejor tratamiento para la paciente seria la paratiroidectomia, sin embargo aún se carece de exámenes necesarios para el tratamiento tanto del hiperparatiroidismo y de la litiasis renal como centellograma de paratiroides y una tomografía computarizada. | spa |
| dc.description.abstract | Introduction: Primary hyperparathyroidism consists in the increased levels of parathyroid hormone (PTH), the clinical picture is characterized by symptoms of hypercalcemia, nephrolithiasis, bone mineral disease, neuromuscular symptoms, there are also asymptomatic presentations; nephrolithiasis occurs in 4-15% of patients, and the disease usually occurs in women at menopause. Case Report: Female patient, 65 years of age who presented with a clinical picture characterized by lower abdominal pain of mild intensity that radiates to lower back accompanied by dysuria, polyuria, dark urine, urgency and headache of moderate intensity, the patient reported recurrence of this symptoms. Her lab tests reveal this information calcemia of 12 mg/dl, 310 mg/24 hour urine calcium, serum phosphorus 2.1 mg/dl, phosphorus 150 mg/24 hours in urine, magnesium 2.2 mg/dl, PTH 120 pg/ml which reveal the diagnosis of primary hyperparathyroidism. Her renal ultrasound showed bilateral kidney stones and bone densitometry at the lumbar spine shows osteopenia and osteoporosis in femur head with T score -1 and -2 respectively. Other tests are ordered and alendronate and parathyroid surgery is recommended. Conclusions: The best treatment for the patient would be the parathyroidectomy, however still lacks examinations necessary for the treatment of both hyperparathyroidism and renal lithiasis, its necessary parathyroid scintigraphy and computed tomography. | eng |
| dc.format.mimetype | spa | |
| dc.identifier.issn | 26107988 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12442/4596 | |
| dc.language.iso | spa | spa |
| dc.publisher | Sociedad Venezolana de Farmacología y Terapéutica | spa |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess | spa |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
| dc.source | Archivos Venezolanos de Farmacología y Terapéutica | spa |
| dc.source | Vol 38, No. 2 (2019) | spa |
| dc.source.uri | http://revistaavft.com/images/revistas/2019/avft_3_2019/15_hiperparatiroidismo_primario.pdf | |
| dc.subject | Hiperparatiroidismo | spa |
| dc.subject | Nefrolitiasis | spa |
| dc.subject | Cálculos renales | spa |
| dc.subject | Osteoporosis | spa |
| dc.subject | Hyperparathyroidism | eng |
| dc.subject | Nephrolithiasis | eng |
| dc.title | Hipertiroidismo primario con nefrolitiasis en mujer menopaúsica a propósito de un caso | spa |
| dc.title.alternative | Primary hyperparathyroidism with nephrolithiasis in a menopausal woman with regard to a case | eng |
| dc.type | article | eng |
| dc.type.driver | article | eng |
| dcterms.references | Wermers, R., Khosla, S., Atkinson, E., & al, e. (2006). Incidence of primary hyperparathyroidism in Rochester, Minnesota. J Bone Miner Res , 171-177 | eng |
| dcterms.references | Michael, A., & Levine, M. (2005). Primary hyperparathyroidism: 7000 years of progress. Cleveland Clin J Med , 1084-1098. | eng |
| dcterms.references | Rao, D., Agarwal, G., Talpos, G., & al, e. (2002). Role of vitamin D and calcium nutrition in disease expression and parathyroi tumor growth in primary hyperparathyroidism: a global perspective. J Bone Miner Res , N75-N80 | eng |
| dcterms.references | Rejnmark, L., Vestergaard, P., & Mosekilde, L. (2011). Nephrolithiasis and renal calcifications in primary huperparathyroidism. J Clin Endocrinol Metab , 2377-85. | eng |
| dcterms.references | Marx, S. (2011). Hyperparathyroid genes: sequences reveal andswers and questions. Endocr Pract, 18-27. | eng |
| dcterms.references | Vestergaard, P., Mollerup, C., Frokjaer, V., Christiansen, P., Blichert-Toff, M., & Mosekildee, L. (2000). Cohort study of risk of fracture before and after surgery for primary hyperparathiroidism. BMJ , 598-602. | eng |
| dcterms.references | Parks, J., Coe, F., A, E., & Worcester, E. (2008). Clinical and laboratory characteristics of calcium-stone formers with and without primary hiperparathyroidism. Br J Urol , 670-678. | eng |
| dcterms.references | Marcocci, C., & Centani, F. (2011). Primary Hiperparathyroidism. N Eng J Med, 2389-2397. | eng |
| dcterms.references | Mollerup, C., Vestergaard, P., Gedso, V., Mosekilde, L., Christiansen, P., & Blichert-Toff, M. (2002). Risk of renal stone events in primary hyperparathiroidism before and after parathyroid surgery: controlled retrospective follow up study. BMJ , 807-810. | eng |
| dcterms.references | Udelsman, R., Lin, Z., & Donovan, P. (2011). The superiority of minimally invasive parathyroidectomy based on 1650 consecutive patients with primary hyperparathyroidism. Ann Surg, 585-591. | eng |
| dcterms.references | Vignali, E., Picone, A., Materazzi, G., & al, e. (2002). A quick intraoperative parathyroid hormone assay in the surgical managemente of patients with primary hyperparathyroidism. a study of 206 consecutive cases. Eu J Endocrinol, 783-788. | eng |
| dcterms.references | Rubin, M., Bilezikian, J., McMahon, D., & al, e. (2008). The natural history of primary hyperparathyroidism with or witouth parathyroid surgery after 15 years. J Clin Endocrinol Metab, 3462-3470. | eng |
| dcterms.references | Bilezikian, J., Khan, A., & Potts, J. (2009). Guidelines for the management of asymptomatic primary huperparathyroidism: summary statement from the Third International Workshop. J Clin Endocrinol Metabol, 335-339. | eng |
| dcterms.references | Rao, S., Honasoge, M., Divine, G., & al, e. (2000). Effect of vitamin D nutrition on parathyroid adenoma weigh; pathogenetic and clinical implications. J Clin Endocrinol Metab , 1054-1058 | eng |
| dcterms.references | Grey, A., Stapleton, J., Evans, M., Tatnell, M., & Reid, I. (1996). Effect of hormone replacement therapy on bone mineal desinsity in posmenopausal women with mild primary hyperparathyroidism: a randomized, contolled trial. Ann Intern Med, 360-368. | eng |
| oaire.version | info:eu-repo/semantics/publishedVersion | eng |